Calcium Phosphate and Incretins

U

University of Jena

Status

Completed

Conditions

Healthy Men

Treatments

Dietary Supplement: calcium phosphate
Other: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01296997
LSEP H45-10

Details and patient eligibility

About

The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Enrollment

10 patients

Sex

Male

Ages

20 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

healthy men

Exclusion criteria

intake of dietary supplements and chronic diseases

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

10 participants in 2 patient groups, including a placebo group

calcium phosphate
Experimental group
Treatment:
Dietary Supplement: calcium phosphate
placebo
Placebo Comparator group
Treatment:
Other: placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems